Abstract. Aim: Triple-negative breast cancer (TNBC), defined by the absence of receptors for estrogen, progesterone and human epithelial receptor 2 (HER2), is a recalcitrant disease in need of effective therapy. We previously isolated very-highlyTriple-negative breast cancer (TNBC), defined by the absence of receptors for estrogen, progesterone and human epithelial receptor 2 (HER2), is a recalcitrant disease in need of effective therapy (1, 2).We previously developed a highly-invasive, TNBC variant using serial orthotopic implantation of MDA-MB-231 human breast cancer expressing red fluorescent protein (MDA-MB-231-RFP) in nude mice (3). MDA-MB-231-RFP was implanted orthotopically into the right lower mammary gland. After the orthotopic tumors grew, they were re-6273